About RejuvenAir
RejuvenAir is a Healthcare company based in Lexington (United States) founded in 2006. Cryosurgical device for chronic bronchitis and COPD treatment is developed. RejuvenAir has raised $174.02 million across 15 funding rounds from investors including Horizon Tech Finance, SV Health Investors and Ascension Ventures. RejuvenAir offers products and services including RejuvenAir System and SPRAY-CB Clinical Trial. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is CSA MEDICAL, INC. Its competitors include Nuvaira, Asthmatx and D R Burton; 2 of its 3 listed competitors have raised funding.
Company details
RejuvenAir was founded in 2006 and is located in Lexington, United States. A cryosurgical system targeting chronic bronchitis and COPD is developed within the medical device sector. Metered doses of cryogen spray are delivered via software-controlled dosimetry and specialized catheters to flash freeze damaged airway surfaces. Mucous production, cough, and inflammation are thereby reduced in affected patients. Operations focus on respiratory therapy innovations for clinical applications.
- Headquarters Lexington, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website rejuvenair.com
- Social LinkedIn
- Legal Name Csa Medical, Inc.
- Total Equity Funding$174.02M (USD)
in 15 rounds
- Latest Funding Round$2.91M (USD), Series F
Jun 2026
- InvestorsHorizon Tech Finance
& 8 more
Products & Services of RejuvenAir
RejuvenAir offers a comprehensive portfolio of products and services, including RejuvenAir System and SPRAY-CB Clinical Trial.
Applies liquid nitrogen to treat Chronic Bronchitis airways.
Evaluates cryotherapy for reducing COPD symptoms.
Funding Insights of RejuvenAir
RejuvenAir has successfully raised a total of $174.02M across 15 strategic funding rounds. The most recent funding activity was a Series F round of $2.91 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $174.02M
- Total Rounds 15
- Last Round Series F — $2.91M
- First Round $6.23M
(Jun 2007)
- Investors Count 9
Latest 10 of 15 funding rounds of RejuvenAir with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $2.91M | Series F | – | – | – |
| Aug 2024 | $59.66M | Series F | – | – | – |
| Feb 2019 | $45.22M | Series E | – | – | – |
| Feb 2019 | $5.08M | Debt – Conventional | – | – | – |
| Oct 2018 | $8M | Series D | – | Ascension Ventures | |
| Oct 2018 | $15M | Debt – Venture | – | – | |
| Jun 2017 | $4.18M | Debt – Conventional | – | – | – |
| Dec 2016 | $2.9M | Series C | – | – | – |
| Jul 2015 | $6.56M | Debt – Conventional | – | – | – |
| Apr 2015 | $2.93M | Debt – Conventional | – | – | – |
9 investors in total: 9 institutional.
Investors in RejuvenAir
RejuvenAir has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include Horizon Tech Finance, SV Health Investors and Ascension Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on early-stage healthcare startups | svhealthinvestors.com | Boston, United States | ||
Strategic investments in healthcare technologies and data innovations. | ascensionventures.org | |||
Early-stage life sciences and tech focused VC firm funding companies in the US | intersouth.com | Durham, United States | ||
Structured debt is provided to life sciences and technology firms. | 2004 | horizontechfinance.com | Farmington, United States | |
Private equity firm focused on healthcare and tech-enabled companies | blueheroncap.com | Richmond, United States | ||
Venture capital investments are guided by disruptive innovation theories. | roseparkadvisors.com | Boston, United States | ||
Guide Medical Ventures is focused on funding and developing innovative medical devices. | 2011 | guidemedventures.com | ||
Venture capital and transaction advisory services for B2B tech companies. | firstanalysis.com | |||
Technology companies are funded by this venture capital firm. | newmarketsvp.com | Howard County, United States |
Investor details for RejuvenAir
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RejuvenAir
7 people are tracked at RejuvenAir (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Freddy Cannady | VP Operations | Leadership |
Wendelin Maners | President and CEO | Leadership |
James McMaster | VP Finance & Administration | Leadership |
Tom Mulcahey, Ph.D. | COO | Leadership |
Loraine Calderon | Clinical Program Manager | Team |
Carla R. | Accounting Clerk II & Office Manager | Team |
Heather Nigro | SVP, Regulatory/Quality/Clinical Affairs | Team |
Complete people profiles for RejuvenAir
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of RejuvenAir
3 dated milestones of RejuvenAir across 20 years, from founding to its latest funding, stage changes and deals.
- Founded RejuvenAir is founded.
- Funding First funding round of $6.2M.
- Funding Latest funding round, Series F, of $2.9M.
Competitors of RejuvenAir
RejuvenAir has 3 listed competitors in our database, 2 of them funded. They include Nuvaira, Asthmatx and D R Burton.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nuvaira.com | 2008 | Minneapolis, United States | $233.15M | 57 | A catheter-based system for COPD treatment is developed and provided. | |
| asthmatx.com | 2003 | Sunnyvale, United States | $50M | Bronchial thermoplasty devices are developed for adult asthma treatment. | ||
| drburtonhpi.com | 2015 | Raleigh, United States | Provides comprehensive products for positive pressure therapy in lung disease patients. |
Detailed competitors of RejuvenAir
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RejuvenAir
The website of RejuvenAir (rejuvenair.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 87.7% vs previous month
Websites whose visitors overlap most with RejuvenAir. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
mylungsmylife.org | mylungsmylife.org | 100% | #1,089,421 | – |
Top companies in Pulmonology
3 companies that operate in the same segment as RejuvenAir (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rejuvenair
Complete news archive for RejuvenAir
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RejuvenAir
RejuvenAir was founded in 2006 and raised its 1st funding round 1 year after it was founded.
RejuvenAir is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
RejuvenAir is a funded company, having raised a total of $174.02M across 15 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $2.93M, raised on Jun 2007.
RejuvenAir was founded in 2006 and is located in Lexington, United States. A cryosurgical system targeting chronic bronchitis and COPD is developed within the medical device sector. Metered doses of cryogen spray are delivered via software-controlled dosimetry and specialized catheters to flash freeze damaged airway surfaces. Mucous production, cough, and inflammation are thereby reduced in affected patients. Operations focus on respiratory therapy innovations for clinical applications.
RejuvenAir's top competitors include Nuvaira, Asthmatx and D R Burton.
RejuvenAir offers RejuvenAir System and SPRAY-CB Clinical Trial.
RejuvenAir has 9 investors. Key investors include Horizon Tech Finance, SV Health Investors, Ascension Ventures, Intersouth Partners, and Blue Heron Capital.
RejuvenAir operates through Csa Medical, Inc..